NO146538C - Analogifremgangsmaate for fremstilling av fysiologisk aktive n-substituerte prostaglandinkarboksamider - Google Patents

Analogifremgangsmaate for fremstilling av fysiologisk aktive n-substituerte prostaglandinkarboksamider

Info

Publication number
NO146538C
NO146538C NO2379/73A NO237973A NO146538C NO 146538 C NO146538 C NO 146538C NO 2379/73 A NO2379/73 A NO 2379/73A NO 237973 A NO237973 A NO 237973A NO 146538 C NO146538 C NO 146538C
Authority
NO
Norway
Prior art keywords
carboxamids
prostaglandine
substituted
preparation
physiologically active
Prior art date
Application number
NO2379/73A
Other languages
English (en)
Norwegian (no)
Other versions
NO146538B (no
Inventor
Thomas Ken Schaaf
Hans-Jurgen Ernst Hess
Leonard Joseph Czuba
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to NO752272A priority Critical patent/NO146773C/no
Publication of NO146538B publication Critical patent/NO146538B/no
Publication of NO146538C publication Critical patent/NO146538C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
NO2379/73A 1972-06-07 1973-06-06 Analogifremgangsmaate for fremstilling av fysiologisk aktive n-substituerte prostaglandinkarboksamider NO146538C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO752272A NO146773C (no) 1972-06-07 1975-06-25 Utgangsforbindelse for fremstilling av n-substituerte prostaglandin-karboksamider

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26051872A 1972-06-07 1972-06-07

Publications (2)

Publication Number Publication Date
NO146538B NO146538B (no) 1982-07-12
NO146538C true NO146538C (no) 1982-10-20

Family

ID=22989486

Family Applications (2)

Application Number Title Priority Date Filing Date
NO2379/73A NO146538C (no) 1972-06-07 1973-06-06 Analogifremgangsmaate for fremstilling av fysiologisk aktive n-substituerte prostaglandinkarboksamider
NO740850A NO142784C (no) 1972-06-07 1974-03-11 Forbindelse for fremstilling av n-substituerte prostaglandin-karboksamider

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO740850A NO142784C (no) 1972-06-07 1974-03-11 Forbindelse for fremstilling av n-substituerte prostaglandin-karboksamider

Country Status (24)

Country Link
JP (2) JPS5715591B2 (US20030199744A1-20031023-C00003.png)
AR (1) AR207434A1 (US20030199744A1-20031023-C00003.png)
AT (1) AT340069B (US20030199744A1-20031023-C00003.png)
BE (1) BE800580A (US20030199744A1-20031023-C00003.png)
CA (1) CA985280A (US20030199744A1-20031023-C00003.png)
CH (3) CH591511A5 (US20030199744A1-20031023-C00003.png)
CS (1) CS200166B2 (US20030199744A1-20031023-C00003.png)
DD (2) DD115687A5 (US20030199744A1-20031023-C00003.png)
DE (1) DE2329092A1 (US20030199744A1-20031023-C00003.png)
ES (3) ES415611A1 (US20030199744A1-20031023-C00003.png)
FI (1) FI58327C (US20030199744A1-20031023-C00003.png)
FR (2) FR2187344B1 (US20030199744A1-20031023-C00003.png)
GB (2) GB1439511A (US20030199744A1-20031023-C00003.png)
HU (3) HU170200B (US20030199744A1-20031023-C00003.png)
IE (1) IE38058B1 (US20030199744A1-20031023-C00003.png)
IL (2) IL42385A (US20030199744A1-20031023-C00003.png)
IN (1) IN138966B (US20030199744A1-20031023-C00003.png)
LU (1) LU67754A1 (US20030199744A1-20031023-C00003.png)
NL (2) NL160814C (US20030199744A1-20031023-C00003.png)
NO (2) NO146538C (US20030199744A1-20031023-C00003.png)
PH (2) PH14204A (US20030199744A1-20031023-C00003.png)
SE (3) SE415883B (US20030199744A1-20031023-C00003.png)
YU (1) YU36498B (US20030199744A1-20031023-C00003.png)
ZA (1) ZA733763B (US20030199744A1-20031023-C00003.png)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX3291E (es) * 1975-04-23 1980-08-22 Upjohn Co Procedimiento para preparar analogos de prostaglandinas
US6395787B1 (en) 2000-02-08 2002-05-28 Allergan Sales, Inc. Ocular hypotensive lipids
US6476064B1 (en) * 2001-06-13 2002-11-05 Allergan, Inc. Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3187043A (en) * 1962-05-18 1965-06-01 Monsanto Co Monohalophosphonium halides

Also Published As

Publication number Publication date
CH591511A5 (US20030199744A1-20031023-C00003.png) 1977-09-30
HU170200B (US20030199744A1-20031023-C00003.png) 1977-04-28
FR2187344A1 (US20030199744A1-20031023-C00003.png) 1974-01-18
ES415611A1 (es) 1976-07-16
FR2187344B1 (US20030199744A1-20031023-C00003.png) 1977-10-28
NL7307867A (US20030199744A1-20031023-C00003.png) 1973-12-11
NL160814C (nl) 1979-12-17
IL51525A0 (en) 1977-04-29
JPS5731692A (en) 1982-02-20
CH593929A5 (US20030199744A1-20031023-C00003.png) 1977-12-30
CA985280A (en) 1976-03-09
IN138966B (US20030199744A1-20031023-C00003.png) 1976-04-17
AU5643173A (en) 1974-12-05
GB1439511A (en) 1976-06-16
SE7608224L (sv) 1976-07-19
CH605887A5 (US20030199744A1-20031023-C00003.png) 1978-10-13
PH14204A (en) 1981-04-01
NO142784C (no) 1980-10-15
SE7608225L (sv) 1976-07-19
ES430417A1 (es) 1977-03-01
NO146538B (no) 1982-07-12
NO142784B (no) 1980-07-07
FR2273814B1 (US20030199744A1-20031023-C00003.png) 1977-07-08
LU67754A1 (US20030199744A1-20031023-C00003.png) 1973-12-14
ATA504873A (de) 1977-03-15
BE800580A (fr) 1973-12-07
JPS5715591B2 (US20030199744A1-20031023-C00003.png) 1982-03-31
ES430416A1 (es) 1976-10-16
IE38058L (en) 1973-12-07
DD115687A5 (US20030199744A1-20031023-C00003.png) 1975-10-12
HU170491B (US20030199744A1-20031023-C00003.png) 1977-06-28
FI58327B (fi) 1980-09-30
HU170487B (US20030199744A1-20031023-C00003.png) 1977-06-28
YU152673A (en) 1982-02-25
YU36498B (en) 1984-02-29
IE38058B1 (en) 1977-12-21
AR207434A1 (es) 1976-10-08
NL160814B (nl) 1979-07-16
FR2273814A1 (fr) 1976-01-02
IL42385A (en) 1979-10-31
JPS4954350A (US20030199744A1-20031023-C00003.png) 1974-05-27
DD109211A5 (US20030199744A1-20031023-C00003.png) 1974-10-20
FI58327C (fi) 1981-01-12
ZA733763B (en) 1974-04-24
AT340069B (de) 1977-11-25
NL7812163A (nl) 1979-04-27
GB1439512A (en) 1976-06-16
SE418744B (sv) 1981-06-22
IL42385A0 (en) 1973-07-30
NO740850L (no) 1973-12-10
DE2329092A1 (de) 1974-01-03
PH13092A (en) 1979-11-27
CS200166B2 (en) 1980-08-29
SE415883B (sv) 1980-11-10

Similar Documents

Publication Publication Date Title
NO138335C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive alkanolaminer
NO140381C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner
NO143460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO141800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO143575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive prostansyre-derivater
NO138566C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater
NO149281C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater
NO145056C (no) (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
NO140977C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-amino-1,4-dihydropyridiner
NO138999C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner
NO137899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n (1h-tetrazol-5-yl)-kinaldamider
NO142838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
NO141850C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolderivater.
NO143064C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner
NO143741C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive prostaglandinforbindelser av e- og f-serien
SE400551B (sv) Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat
NO137858C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner
NO139088C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2beta,16beta-diamino-5alfa-androstaner
NO142077C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-cyclohexyl-3-pyrrolidinyl)-benzamider
NO137728C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
NO138025C (no) Analogifremgangsmaate til fremstilling av antimykotisk virksomme 1-etyl-imidazoler
NO138026C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive n-benzhydryl-n`-p-hydroksybenzylpiperaziner
NO145238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater